Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination
Yu Zheng(Howard Hughes Medical Institute), Daniel A. Haber(Howard Hughes Medical Institute), Erin Emmons(Harvard University), David T. Miyamoto(Broad Institute), David T. Ting(Massachusetts General Hospital), Nicole Vincent Jordan(Harvard University), John Milner(Brown University), James P. Sullivan(Australian National University), Min Yu(Howard Hughes Medical Institute), Richard J. Lee(La Roche College), Chin‐Lee Wu(Massachusetts General Hospital), Niyati Desai(Jet Propulsion Laboratory), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Lecia V. Sequist(Harvard University), Mehmet Toner(Center for Cancer Research), Nicola Aceto(ETH Zurich), Valentine Comaills(Harvard University), Rushil Desai(Harvard University), Robert Morris(Massachusetts General Hospital), Sridhar Ramaswamy(Harvard University), Wilhelm Haas(Harvard University)
Cited by 143
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k